Walleye Capital LLC Has $5.11 Million Stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Walleye Capital LLC increased its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report) by 294.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 76,903 shares of the company’s stock after purchasing an additional 57,413 shares during the period. Walleye Capital LLC’s holdings in Ryan Specialty were worth $5,106,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Hollencrest Capital Management bought a new position in Ryan Specialty during the 3rd quarter worth $25,000. Assetmark Inc. acquired a new position in Ryan Specialty in the 3rd quarter worth about $34,000. GAMMA Investing LLC increased its holdings in Ryan Specialty by 96.4% in the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock worth $35,000 after purchasing an additional 297 shares in the last quarter. Crewe Advisors LLC bought a new stake in shares of Ryan Specialty in the 2nd quarter valued at about $39,000. Finally, Signaturefd LLC grew its position in shares of Ryan Specialty by 12.3% in the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock valued at $89,000 after buying an additional 148 shares during the last quarter. 84.82% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Ryan Specialty

In other news, Director David P. Bolger sold 7,055 shares of Ryan Specialty stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $70.88, for a total value of $500,058.40. Following the transaction, the director now owns 78,149 shares in the company, valued at approximately $5,539,201.12. The trade was a 8.28 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Mark Stephen Katz sold 14,790 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $71.39, for a total value of $1,055,858.10. Following the transaction, the executive vice president now owns 12,386 shares in the company, valued at approximately $884,236.54. This represents a 54.42 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on RYAN. The Goldman Sachs Group upped their target price on Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research report on Wednesday, October 9th. Wells Fargo & Company increased their price target on Ryan Specialty from $63.00 to $70.00 and gave the stock an “equal weight” rating in a report on Thursday, October 10th. Bank of America increased their price objective on Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research note on Thursday, October 10th. BMO Capital Markets raised Ryan Specialty from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $65.00 to $75.00 in a research note on Tuesday, September 24th. Finally, Barclays increased their price target on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, November 21st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $71.67.

Check Out Our Latest Analysis on RYAN

Ryan Specialty Price Performance

Ryan Specialty stock opened at $75.40 on Monday. Ryan Specialty Holdings, Inc. has a one year low of $41.49 and a one year high of $75.97. The business has a fifty day moving average price of $70.23 and a 200-day moving average price of $63.34. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a market capitalization of $19.74 billion, a P/E ratio of 97.92, a PEG ratio of 1.71 and a beta of 0.62.

Ryan Specialty (NYSE:RYANGet Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.41. The company had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The firm’s quarterly revenue was up 20.5% on a year-over-year basis. During the same quarter last year, the company earned $0.32 earnings per share. As a group, equities research analysts forecast that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current year.

Ryan Specialty Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were paid a dividend of $0.11 per share. This represents a $0.44 annualized dividend and a yield of 0.58%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio is 57.14%.

Ryan Specialty Company Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

See Also

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.